Indinavir

DRUG6 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health Clinical Center (CC), French National Agency for Research on AIDS and Viral Hepatitis, Kirby Institute, Istituto Superiore di Sanità

Conditions

Cardiovascular DiseaseClassical Kaposi's SarcomaHIV InfectionHIV InfectionsHIV-Associated Lipodystrophy SyndromeHealthy

Phase 1

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

CompletedNCT00001644

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infection

Start: 1997-03-03End: 2010-02-17Updated: 2017-07-02

Phase 2

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

TerminatedNCT00120783

French National Agency for Research on AIDS and Viral HepatitisHIV Infections

Start: 2002-02-28End: 2003-08-31Target: 40Updated: 2007-01-18

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

CompletedNCT00362310

Istituto Superiore di SanitàClassical Kaposi's Sarcoma

Start: 2003-06-30End: 2007-07-31Target: 28Updated: 2008-04-14

Phase 4

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

CompletedNCT00050180

National Institutes of Health Clinical Center (CC)Healthy, HIV Infections

Start: 2002-11-22End: 2007-08-24Updated: 2017-07-02

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

CompletedNCT00192660

Kirby InstituteCardiovascular Disease, HIV-Associated Lipodystrophy Syndrome

Start: 2003-02-28End: 2007-12-31Updated: 2012-04-12

Unknown Phase

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

TerminatedNCT00122590

French National Agency for Research on AIDS and Viral HepatitisHIV Infections

Start: 2002-07-31End: 2005-03-31Target: 115Updated: 2005-08-01